PANCO: AN OPEN-LABEL, SINGLE-ARM PILOT STUDY OF ONCOSIL IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA IN COMBINATION WITH FOLFIRINOX OR GEMCITABINE+NAB-PACLITAXEL CHEMOTHERAPIES

Daniel Croagh  1     Vu Kwan  2     Nam Q Nguyen  3     David Williams  4     Natalie Phillips  5     Edmund M Godfrey  6     Anna Kraszewski  7     Thomas Maher  7     Paul Ross  8    
1 Monash Health,Melbourne,Australia
2 Westmead Hospital,Sydney,Australia
3 Royal Adelaide Hospital,Adelaide,Australia
4 St Vincent's Hospital,Sydney,Australia
5 Hammersmith Hospital,London,United Kingdom
6 Addenbrooke's Hospital,Cambridge,United Kingdom
7 OncoSil Medical Ltd,Sydney,Australia
8 Guy's and

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing